For the Inventor, By the Inventor

Enter assignee name

Redwood City, CA, United States of America

Genomic Health, Inc.

USPTO Granted Patents = 61

% Expired Patents = 4.9

CIPO Patents = 19

EPO Patents = 43

Trademarks = 22

Forward Citations = 1,050

Loading Chart...

Loading Chart...

56 inventors (with patents filed for the assignee):

Joffre B Baker (44 out of 44 patents)

Steven Shak (24 out of 24 patents)

Soonmyung Paik (19 out of 20 patents)

4. Wayne Cowens (16 out of 16 patents)

5. Michael C Kiefer (15 out of 43 patents)

6. Maureen T Cronin (14 out of 28 patents)

7. James Hackett (14 out of 16 patents)

8. Drew Watson (13 out of 13 patents)

9. Tara Maddala (10 out of 10 patents)

10. Dejan Knezevic (10 out of 10 patents)

11. Steve Shak (10 out of 10 patents)

12. Michael R Crager (8 out of 8 patents)

13. John L Bryant (8 out of 10 patents)

14. Kim Clark (8 out of 8 patents)

15. Audrey Goddard (7 out of 632 patents)

Core Competencies:

DNA Methylation

Gene Expression

Cancer Prognosis

RNA Processing

Bladder Cancer

Kidney Cancer

Breast Cancer

Colorectal Cancer

Chemotherapy Response

Mutation Analysis

Recurrence Prediction

Intronic RNA

61 patents: Sort by Forward Citations

1. 12675922 - Systems and methods for transferring markings (2026-07-07),

2. 12584179 - DNA methylation and mutational analysis methods for bladder cancer surveillance (2026-03-24),

3. 12412642 - Method to use gene expression to determine likelihood of clinical outcome of renal cancer (2025-09-09),

4. 11807900 - Systems and methods for pre-analytical substrate processing (2023-11-07),

5. 11776664 - Method to use gene expression to determine likelihood of clinical outcome of renal cancer (2023-10-03),

6. 11649506 - DNA methylation and mutational analysis methods for bladder cancer surveillance (2023-05-16),

7. 11551782 - Gene expression profile algorithm for calculating a recurrence score for a patient with kidney cancer (2023-01-10),

8. 11220715 - Gene expression markers for breast cancer prognosis (2022-01-11),

9. 11149297 - Methods for depleting RNA from nucleic acid samples (2021-10-19),

10. 11011252 - Gene expression profile algorithm and test for determining prognosis of prostate cancer (2021-05-18),

11. 10892038 - Method to use gene expression to determine likelihood of clinical outcome of renal cancer (2021-01-12),

12. 10619215 - Prediction of likelihood of cancer recurrence (2020-04-14),

13. 10260104 - Method for using gene expression to determine prognosis of prostate cancer (2019-04-16),

14. 10241114 - Gene expression profiling in biopsied tumor tissues (2019-03-26),

15. 10181008 - Gene expression profile algorithm for calculating a recurrence score for a patient with kidney cancer (2019-01-15),

Company Overview

Genomic Health, Inc., based in Redwood City, California, specializes in gene expression analysis to enhance cancer prognosis and treatment decisions. The company focuses on advanced technologies such as DNA methylation and RNA processing, which are pivotal in understanding various cancers, including bladder, kidney, breast, and colorectal cancers. By leveraging its expertise in molecular diagnostics, Genomic Health aims to provide clinicians and patients with critical insights that guide personalized cancer care.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

61 Patents

#37 in Redwood City, CA

#1,388 in California

#5,917 in US

#11,930 in the World

Redwood City, CA, United States of America

Genomic Health, Inc.

Forward Citations = 1,050

56 inventors:

Joffre B Baker (44 out of 44 patents)

Steven Shak (24 out of 24 patents)

Soonmyung Paik (19 out of 20 patents)

4. Wayne Cowens (16 out of 16 patents)

5. Michael C Kiefer (15 out of 43 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Genomic Health, Inc.. Retrieved from https://idiyas.com/company/genomic-health

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…